AST - 1.65 Pre-market now at 1.70/1.85 Asterias Provides Six Month Data Readout for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury http://stockcharts.com/c-sc/sc?s=AST&p=D&b=5&g=0&i=t98124413786&r=1531828720230